Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 26, 2022

SELL
$114.02 - $139.04 $15.6 Million - $19 Million
-136,593 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$115.53 - $141.46 $351,788 - $430,745
-3,045 Reduced 2.18%
136,593 $19.2 Million
Q3 2021

Oct 29, 2021

SELL
$116.66 - $129.06 $911,231 - $1.01 Million
-7,811 Reduced 5.3%
139,638 $16.5 Million
Q2 2021

Jul 29, 2021

BUY
$105.79 - $124.53 $20,100 - $23,660
190 Added 0.13%
147,449 $17.1 Million
Q1 2021

May 06, 2021

BUY
$108.84 - $128.23 $456,801 - $538,181
4,197 Added 2.93%
147,259 $17.6 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $405,615 - $442,004
3,863 Added 2.78%
143,062 $15.7 Million
Q3 2020

Oct 22, 2020

SELL
$91.64 - $111.29 $648,536 - $787,599
-7,077 Reduced 4.84%
139,199 $15.1 Million
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $377,643 - $483,336
4,932 Added 3.49%
146,276 $13.4 Million
Q1 2020

May 07, 2020

BUY
$62.82 - $91.86 $8.38 Million - $12.3 Million
133,400 Added 1679.25%
141,344 $11.2 Million
Q4 2019

Feb 07, 2020

BUY
$78.51 - $87.4 $6,045 - $6,729
77 Added 0.98%
7,944 $690,000
Q3 2019

Oct 16, 2019

BUY
$81.84 - $88.74 $191,423 - $207,562
2,339 Added 42.31%
7,867 $658,000
Q2 2019

Jul 26, 2019

BUY
$72.88 - $85.0 $89,715 - $104,635
1,231 Added 28.65%
5,528 $465,000
Q1 2019

Apr 23, 2019

SELL
$66.22 - $80.06 $3,178 - $3,842
-48 Reduced 1.1%
4,297 $343,000
Q4 2018

Jan 23, 2019

BUY
$65.56 - $74.27 $42,614 - $48,275
650 Added 17.59%
4,345 $314,000
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $19,763 - $23,842
325 Added 9.64%
3,695 $271,000
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $194,010 - $214,129
3,370 New
3,370 $206,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Suncoast Equity Management Portfolio

Follow Suncoast Equity Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Suncoast Equity Management, based on Form 13F filings with the SEC.

News

Stay updated on Suncoast Equity Management with notifications on news.